In total, 86 tumors were analyzed for TP53 mutations (TP53-mut), out of which sequence alterations were identified in 33 cases (38%,), while 53 BC had wild-type TP53 (62%, TP53-wt). The gene discussed is TP53; the disease is breast cancer.